Expression and characterization of dog CYP2D15 using baculovirus expression system

Journal of Biochemistry

Volumn 123, Issue 1, 1998, Pages 162-168

  Tasaki, Takafumi ^a   Nakamura, Akio ^a,c   Itoh, Susumu ^b   Ohashi, Kazuhiko ^a   Yamamoto, Yukio ^a   Masuda, Makihiko ^a   Iwata, Hisato ^a   Kazusaka, Akio ^a   Kamataki, Tetsuya ^b   Fujita, Shoichi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c NIPPON SHINYAKU CO LTD   (Japan)

Author keywords

Baculovirus expression; CYP2D; Cytochrome P450; Dog; Drug metabolism

Indexed keywords

BUNITROLOL; CYTOCHROME P450; DEBRISOQUINE; IMIPRAMINE; POLYCLONAL ANTIBODY;

ANIMAL CELL; ARTICLE; BACULOVIRUS; CROSS LINKING; DOG; ENZYME SPECIFICITY; EXPRESSION VECTOR; HYDROXYLATION; IMMUNOBLOTTING; LIVER MICROSOME; NONHUMAN; SPECIES DIFFERENCE;

ANIMALIA; CANIS FAMILIARIS; INSECTA; UNIDENTIFIED BACULOVIRUS;

EID: 0031891642     PISSN: 0021924X     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.jbchem.a021905     Document Type: Article

References (41)

1. Nelson, D.R., Koymans, L., Kamataki, T., Stegeman, J.J., Feyereisen, R., Waxman, D.J., Waterman, M.R., Gotoh, O., Coon, M.J., Estabrook, R.W., Gunsalus, I.C., and Nebert, D.W. (1996) P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 6, 1-42
2. Kroemer, H.K. and Eichelbaum, M. (1995) "It's the genes, stupid." Molecular bases and clinical consequences of genetic cytochrome P450 2D6 polymorphism. Life Sci. 56, 2285-2298
3. Eichelbaum, M., Baur, M.P., Dengler, H.J., Osikowska-Evers, B.O., Tieves, G., Zekorn, C., and Rittner, C. (1987) Chromosomal assignment of human cytochrome P-450 (debrisoquine/ sparteine type) to chromosome 22. Br. J. Clin. Pharmacol. 23, 455-458
4. Daly, A.K., Brockmoller, J., Broly, F., Eichelbaum, M., Evans, W.E., Gonzalez, F.J., Huang, J.D., Idle, J.R., Ingelman-Sundberg, M., Ishizaki, T., Jacqz-Aigrain, E., Meyer, U.A., Nebert, D.W., Steen, V.M., Wolf, C.R., and Zanger, U.M. (1996) Nomenclature for human CYP2D6 alleles. Pharmacogenetics 6, 193-201
5. Kagimoto, M., Heim, M., Kagimoto, K., Zeugin, T., and Meyer, U.A. (1990) Multiple mutations of the human cytochrome P450IID6 gene (CYP2D6) in poor metabolizers of debrisoquine. Study of the functional significance of individual mutations by expression of chimeric genes. J. Biol. Chem. 265, 17209-17214
6. Evert, B., Griese, E.U., and Eichelbaum, M. (1994) A missense mutation in exon 6 of the CYP2D6 gene leading to a histidine 324 to proline exchange is associated with the poor metabolizer phenotype of sparteine. Naunyn-Schmiedeberg's Arch. Pharmacol. 350, 434-439
7. Gonzalez, F.J., Skoda, R.C., Kimura, S., Umeno, M., Zanger, U.M., Nebert, D.W., Gelboin, H.V., Hardwick, J.P., and Meyer, U.A. (1988) Characterization of the common genetic defect in humans deficient in debrisoquine metabolism. Nature 331, 442-446
8. Ellis, S.W., Hayhurst, G.P., Smith, G., Lightfoot, T., Wong, M.M., Simula, A.P., Ackland, M.J., Sternberg, M.J., Lennard, M.S., Tucker, G.T., and Wolf, C.R. (1995) Evidence that aspartic acid 301 is a critical substrate-contact residue in the active site of cytochrome P450 2D6. J. Biol. Chem. 270, 29055-29058
9. Imaoka, S., Yamada, T., Hiroi, T., Hayashi, K., Sakaki, T., Yabusaki, Y., and Funae, Y. (1996) Multiple forms of human P450 expressed in Saccharomyces cerevisiae. Systematic characterization and comparison with those of the rat. Biochem. Pharmacol. 51, 1041-1050
10. Gillam, E.M., Guo, Z., Martin, M.V., Jenkins, C.M., and Guengerich, F.P. (1995) Expression of cytochrome P450 2D6 in Escherichia coli, purification, and spectral and catalytic characterization. Arch. Biochem. Biophys. 319, 540-550
11. Kempf, A.C., Zanger, U.M., and Meyer, U.A. (1995) Truncated human P450 2D6: expression in Escherichia coli, Ni(2+)-chelate affinity purification, and characterization of solubility and aggregation. Arch. Biochem. Biophys. 321, 277-288
12. Evert, B., Eichelbaum, M., Haubruck, H., and Zanger, U.M. (1997) Functional properties of Cyp2d6 1 (wild-type) and Cyp2d6 7 (His(324)Pro) expressed by recombinant baculovirus in insect cells. Naunyn-Schmiedeberg's Arch. Pharmacol. 355, 309-318
13. Paine, M.J.I., Gilham, D., Roberts, G.C.K., and Wolf, C.R. (1996) Functional high level expression of cytochrome P450 Cyp2d6 using baculoviral expression systems. Arch. Biochem. Biophys. 328, 143-150
14. Ono, S., Tsutsui, M., Gonzalez, F.J., Satoh, T., Masubuchi, Y., Horie, T., Suzuki, T., and Narimatsu, S. (1995) Oxidative metabolism of bunitrolol by complementary DNA-expressed human cytochrome P450 isozymes in a human hepatoma cell line (Hep G2) using recombinant vaccinia virus. Pharmacogenetics 5, 97-102
15. Sakamoto, K., Kirita, S., Baba, T., Nakamura, Y., Yamazoe, Y., Kato, R., Takanaka, A., and Matsubara, T. (1995) A new cytochrome P450 form belonging to the CYP2D in dog liver microsomes: purification, cDNA cloning, and enzyme characterization. Arch. Biochem. Biophys. 319, 372-382
16. O'Reilly, D.R., Miller, L.K., and Luckow, V.A. (1994) Baculovirus Expression Vectors: A Laboratory Manual, pp. 98-103, Oxford University Press, New York
17. Kramer, W. and Fritz, H.J. (1987) Oligonucleotide-directed construction of mutations via gapped duplex DNA in Methods in Enzymology (Wu, R. and Grossman, L., eds.) Vol. 154, pp. 350-367, Academic Press, San Diego
18. Omura, T. and Sato, R. (1964) The carbon monoxide-binding pigment of liver microsomes: I. Evidence for its hemoprotein nature. J. Biol. Chem. 239, 2370-2378
19. Suzuki, T., Narimatsu, S., Fujita, S., Masubuchi, Y., Umeda, S., Imaoka, S., and Funae, Y. (1992) Purification and characterization of a cytochrome P-450 isozyme catalyzing bunitrolol 4-hydroxylation in liver microsomes of male rats. Drug Metab. Dispos. 20, 367-373
20. Laemmli, U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685
21. Omura, T. and Sato, R. (1964) The carbon monoxide-binding pigment of liver microsomes: II. Solubilization, purification, and properties. J. Biol. Chem. 239, 2379-2385
22. Lowry, O.H., Rosebrough, N.J., Farr, A.L., and Randall, R.J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 680-685
23. Ardies, C.M., Lasker, J.M., Bloswick, B.P., and Lieber, C.S. (1987) Purification of NADPH:cytochrome c (cytochrome P-450) reductase from hamster liver microsomes by detergent extraction and affinity chromatography. Anal. Biochem. 162, 39-46
24. Phillips, A.H. and Langdon, R.G. (1962) Hepatic triphosphopyridine nucleotide-cytochrome c reductase: isolation, characterization, and kinetic studies. J. Biol. Chem. 237, 2652-2660
25. Gallagher, S., Winston, S.E., Fuller, S.A., and Hurrell, J.G.R. (1992) Immunoblotting and immunodetection in Current Protocols in Molecular Biology (Ausubel, F.M., Brent, R., Kingston, R.B., Moore, D.D., Seidman, J.G., Smith, J.A., and Struhl, K., eds.) Vol. 1, pp. 10.18.11-10.18.16, Greene Publishing Associates and Wiley-Interscience, New York
26. Nakamura, A., Yamamoto, Y., Tasaki, T., Sugimoto, C., Masuda, M., Kazusaka, A., and Fujita, S. (1995) Anti-peptide antibodies to the P4502D subfamily in rat, dog and man. Xenobiotica 25, 1103-1109
27. Lennard, P.R. (1990) Image analysis for all. Nature 347, 103-104
28. Matsunaga, E., Zanger, U.M., Hardwick, J.P., Gelboin, H.V., Meyer, U.A., and Gonzalez, F.J. (1989) The CYP2D gene subfamily: analysis of the molecular basis of the debrisoquine 4-hydroxylase deficiency in DA rats. Biochemistry 28, 7349-7355
29. Wong, G., Itakura, T., Kawajiri, K., Skow, L., and Negishi, M. (1989) Gene family of male-specific testosterone 16 alpha-hydroxylase (C-P-450(16 alpha)) in mice. Organization, differential regulation, and chromosome localization. J. Biol. Chem. 264, 2920-2927
30. Tsuneoka, Y., Matsuo, Y., Higuchi, R., and Ichikawa, Y. (1992) Characterization of the cytochrome P-450IID subfamily in bovine liver. Nucleotide sequences and microheterogeneity. Eur. J. Biochem. 208, 739-746
31. Jiang, Q., Voigt, J.M., and Colby, H.D. (1995) Molecular cloning and sequencing of a guinea pig cytochrome P4502D (CYP2D16): high level expression in adrenal microsomes. Biochem. Biophys. Res. Commun. 209, 1149-1156
32. Igarashi, T., Sakuma, T., Isogai, M., Nagata, R., and Kamataki, T. (1997) Marmoset liver cytochrome P450s: study for expression and molecular cloning of their cDNAs. Arch. Biochem. Biophys. 339, 85-91
33. 5 on the stoichiometry of P450 2E1-catalyzed reactions. Arch. Biochem. Biophys. 317, 504-513
34. Lee, C.A., Kadwell, S.H., Kost, T.A., and Serabjit-Singh, C.J. (1995) CYP3A4 expressed by insect cells infected with a recombinant baculovirus containing both CYP3A4 and human NADPH-cytochrome P450 reductase is catalytically similar to human liver microsomal CYP3A4. Arch. Biochem. Biophys. 319, 157-167
35. Buters, J.T., Korzekwa, K.R., Kunze, K.L., Omata, Y., Hardwick, J.P., and Gonzalez, F.J. (1994) cDNA-directed expression of human cytochrome P450 CYP3A4 using baculovirus. Drug Metab. Dispos. 22, 688-692
36. Buters, J.T., Shou, M., Hardwick, J.P., Korzekwa, K.R., and Gonzalez, F.J. (1995) cDNA-directed expression of human cytochrome P450 CYP1A1 using baculovirus. Purification, dependency on NADPH-P450 oxidoreductase, and reconstitution of catalytic properties without purification. Drug Metab. Dispos. 23, 696-701
37. Narimatsu, S., Masubuchi, Y., Hosokawa, S., Ohmori, S., Kitada, M., and Suzuki, T. (1994) Involvement of a cytochrome P4502D subfamily in human liver microsomal bunitrolol 4-hydroxylation. Biol. Pharm. Bull. 17, 803-807
38. Kobayashi, S., Murray, S., Watson, D., Sesardic, D., Davies, D.S., and Boobis, A.R. (1989) The specificity of inhibition of debrisoquine 4-hydroxylase activity by quinidine and quinine in the rat is the inverse of that in man. Biochem. Pharmacol. 38, 2795-2799
39. Ching, M.S., Blake, C.L., Ghabrial, H., Ellis, S.W., Lennard, M.S., Tucker, G.T., and Smallwood, R.A. (1995) Potent inhibition of yeast-expressed CYP2D6 by dihydroquinidine, quinidine, and its metabolites. Biochem. Pharmacol. 50, 833-837
40. Lemoine, A., Gautier, J.C., Azoulay, D., Kiffel, L., Belloc, C., Guengerich, F.P., Maurel, P., Beaune, P., and Leroux, J.P. (1993) Major pathway of imipramine metabolism is catalyzed by cytochromes P-450 1A2 and P-450 3A4 in human liver. Mol. Pharmacol. 43, 827-832
41. Shimada, T., Yamazaki, H., Mimura, M., Inui, Y., and Guengerich, F.P. (1994) Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J. Pharmacol. Exp. Ther. 270, 414-423